Mediclinic International PLC (MDCM.L)
MDCM.L on London Stock Exchange
364.30GBp
19 Oct 2018
364.30GBp
19 Oct 2018
Change (% chg)
-- (--)
-- (--)
Prev Close
364.30
364.30
Open
--
--
Day's High
--
--
Day's Low
--
--
Volume
--
--
Avg. Vol
1,579,674
1,579,674
52-wk High
712.40
712.40
52-wk Low
344.04
344.04
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Mar '18 | 1,465.00 | -0.600 |
| Sep | 1,405.00 | -0.068 | |
| FY 2017 | Mar '17 | 1,466.00 | 0.161 |
| Sep | 1,283.00 | 0.149 | |
| FY 2016 | Mar '16 | 1,097.00 | 0.124 |
| Sep | 1,010.00 | 0.173 |
*Note: Units in Millions ofBritish Pounds
**Note: Units in British Pounds
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Year Ending Mar-18 | 11 | 2,871.38 | 2,989.00 | 2,802.20 | -- |
| Year Ending Mar-19 | 13 | 2,955.57 | 3,006.04 | 2,902.65 | 3,089.65 |
| Year Ending Mar-20 | 13 | 3,101.52 | 3,224.35 | 3,016.10 | 3,223.35 |
| Earnings (per share) | |||||
| Year Ending Mar-18 | 10 | 29.18 | 31.24 | 22.20 | -- |
| Year Ending Mar-19 | 14 | 29.10 | 32.12 | 25.10 | 37.18 |
| Year Ending Mar-20 | 14 | 33.06 | 37.58 | 28.00 | 41.26 |
| LT Growth Rate (%) | 3 | 10.24 | 11.90 | 8.72 | 10.60 |
Sales and Profit Figures in British Pound (GBP);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | 22.09 | 28.18 | 33.64 | |
| P/E High - Last 5 Yrs. | -- | 119.36 | 45.19 | |
| P/E Low - Last 5 Yrs. | -- | 21.64 | 23.75 | |
| Beta | 1.03 | 0.62 | 0.88 | |
| Price to Sales (TTM) | 1.84 | 13.16 | 5.83 | |
| Price to Book (MRQ) | 1.24 | 3.81 | 4.89 | |
| Price to Tangible Book (MRQ) | 2.62 | 4.49 | 6.51 | |
| Price to Cash Flow (TTM) | 13.03 | 16.88 | 22.92 | |
| % Owned Institutions | -- | 8.02 | 2.14 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 1.06 | 1.51 | |
| Dividend Yield - 5 Year Avg | -- | 0.85 | 1.52 | |
| Dividend 5 Year Growth Rate | -- | 10.91 | 5.40 | |
| Payout Ratio(TTM) | 25.43 | 13.91 | 43.85 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | 33.64 | 10.43 | 8.10 | |
| Sales (TTM) vs TTM 1 Yr. Ago | 30.47 | 9.36 | 5.80 | |
| Sales - 5 Yr. Growth Rate | -- | 14.62 | 9.87 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 29.83 | 60.68 | 23.38 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 4.44 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 10.94 | 10.92 | |
| Capital Spending - 5 Yr. Growth Rate | -- | 20.98 | 14.87 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | 1.66 | 6.49 | 2.25 |
| Current Ratio (MRQ) | 1.81 | 6.74 | 3.05 |
| LT Debt to Equity (MRQ) | 47.99 | 48.34 | 12.76 |
| Total Debt to Equity (MRQ) | 49.68 | 59.90 | 17.18 |
| Interest Coverage (TTM) | 6.42 | 38.98 | 37.50 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | 38.30 | 38.88 | 54.87 | |
| Gross Margin - 5 Yr. Avg. | -- | 40.49 | 52.39 | |
| EBITD Margin (TTM) | 18.52 | -- | -- | |
| EBITD - 5 Yr. Avg | -- | 5.45 | 11.01 | |
| Operating Margin (TTM) | 13.17 | 1.66 | 4.07 | |
| Operating Margin - 5 Yr. Avg. | -- | -3.54 | 6.34 | |
| Pre-Tax Margin (TTM) | 11.17 | 8.50 | 5.12 | |
| Pre-Tax Margin - 5 Yr. Avg. | -- | 3.61 | 6.78 | |
| Net Profit Margin (TTM) | 8.84 | 5.58 | 1.39 | |
| Net Profit Margin - 5 Yr. Avg. | -- | 0.95 | 3.03 | |
| Effective Tax Rate (TTM) | 20.85 | 19.86 | 23.24 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 39.74 | 24.16 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 93,364 | 5,404,142 | 808,218,600 | |
| Net Income/Employee (TTM) | 8,253 | -566,511 | 95,058,584 | |
| Receivable Turnover (TTM) | -- | 7.69 | 5.78 | |
| Inventory Turnover (TTM) | -- | 67.61 | 3.63 | |
| Asset Turnover (TTM) | -- | 0.60 | 0.92 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -- | 5.43 | 10.90 | |
| Return on Assets - 5 Yr. Avg. | -- | 6.37 | 12.01 | |
| Return on Investment (TTM) | -- | 6.90 | 14.27 | |
| Return on Investment - 5 Yr. Avg. | -- | 8.03 | 15.60 | |
| Return on Equity (TTM) | -- | 11.00 | 15.99 | |
| Return on Equity - 5 Yr. Avg. | -- | 12.03 | 16.87 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | 30.47 | -- | -- |
| EPS (TTM) % | 5.16 | -- | -- |
| Dividend % | 0.00 | -- | -- |
Note: Units in Millions of US Dollars
Performance for Mediclinic International PLC
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | -8.41 | -10.29 | 60 | 20 |
| 13 Week | -6.16 | -8.59 | 99 | 28 |
| 26 Week | -1.93 | -4.73 | 99 | 18 |
| 52 Week | -22.83 | -28.81 | 78 | 9 |
| YTD | -11.02 | -16.52 | 99 | 9 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
- UPDATE 1-FTSE 100 slips into red on Q3 earnings, Wall Street gloom
- UPDATE 1-South Africa's rand firmer on risk sentiment rally, stocks falter
- UPDATE 1-FTSE 100 swings back down as earnings cause havoc; airlines dive
- Mediclinic flags drop in first-half core profit, shares dive 19 percent
- FTSE 100 rises, led by Pearson; Mediclinic sinks as earnings sag
Institutional Holders
| % Shares Owned: | 40.02% |
| # of Holders: | 266 |
| Total Shares Held: | 295,072,718 |
| 3 Mo. Net Change: | -8,193,928 |
| # New Positions: | 6 |
| # Closed Positions: | 7 |
| # Increased Positions: | 38 |
| # Reduced Positions: | 39 |
| # Net Buyers: | -1 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.